n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine has been researched along with calpain in 1 studies
Studies (n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine) | Trials (n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine) | Recent Studies (post-2010) (n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine) | Studies (calpain) | Trials (calpain) | Recent Studies (post-2010) (calpain) |
---|---|---|---|---|---|
113 | 0 | 9 | 7,019 | 25 | 2,422 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Saini, MK; Sanyal, SN | 1 |
1 other study(ies) available for n-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)phosphatidylethanolamine and calpain
Article | Year |
---|---|
Piroxicam and c-phycocyanin prevent colon carcinogenesis by inhibition of membrane fluidity and canonical Wnt/β-catenin signaling while up-regulating ligand dependent transcription factor PPARγ.
Topics: 2-Naphthylamine; Animals; Apoptosis; Calcium; Calpain; Carcinogenesis; Colonic Neoplasms; Fluorescence Polarization; Fura-2; Intracellular Space; Laurates; Ligands; Male; Membrane Fluidity; Membrane Potentials; Phase Transition; Phosphatidylethanolamines; Phycocyanin; Piroxicam; PPAR gamma; Pyrimidinones; Rats, Sprague-Dawley; Up-Regulation; Wnt Signaling Pathway | 2014 |